More Manzo Pharmaceuticals, Inc. news
Manzo Pharmaceuticals, Inc.OTC: MNZO

Shareholder Meeting

Feb 24, 2022

The original release is unavailable here.

Earlier from Manzo Pharmaceuticals

  • Virtual Special MeetingFeb 22, 2022
  • SEC Suspension of TradingMar 9, 2018
  • New Manzo Pharmaceuticals, Inc. WebsiteOct 31, 2016
  • Manzo Pharmaceuticals, Inc announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.Jul 29, 2016
All Manzo Pharmaceuticals news releases↗